4 unknown, 2 recruiting, 1 active not recruiting, 1 completed. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Unknown 4, Recruiting 2, Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow PET-CT: new trials by email Literature Review of PET-CT trials Research Report on PET-CT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma Ruxolitinib, Positron emission tomography-computed tomography, Bone Marrow Biopsy - T-cell Lymphoma, Graft Versus Host Disease | Phase 2 | Recruiting | Ohio State University Comprehensive Cancer Center | 44 | 2026-02-12 | 2026-10-27 |
| A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations [18F]-4FN, PET-CT - Pilot Study, PET/CT Imaging | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 16 | 2025-11-18 | 2026-09-17 |
| PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Paclitaxel, Cisplatin, Oxaliplatin - Neoplasm, Esophageal, Squamous Cell Carcinoma | Phase 2 | Unknown | Mian XI | 216 | 2019-01-15 | 2021-03-23 |
| Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. Carfilzomib, Lenalidomide, PET-CT - Myeloma | Phase 2 | Active not recruiting | Oslo University Hospital | 53 | 2018-03-16 | 2025-08-08 |
| Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology Surgery, Cisplatin, Mitomycin C - Gastric Adenocarcinoma, Esophagogastric Junction | Phase 2 | Completed | National Cancer Institute (NCI) | 27 | 2017-06-05 | 2025-02-19 |
| PET-CT/MRI in the Radiotherapy for Prostate Cancer PET-CT, PET-MRI - Prostate Cancer | Phase 1 / Phase 2 | Unknown | Xuzhou Medical University | 90 | 2016-09-01 | 2016-06-29 |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL Dexamethasone, vincristine, Cyclophosphamide - Leukemia, Leukemia, Acute | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 80 | 2016-02-14 | 2018-06-21 |
| Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer PET/CT with FDG - Rectal Cancer | Phase 2 | Unknown | University of Sao Paulo | 100 | 2005-09-01 | 2009-04-14 |
Leukemia (2) · Adenocarcinoma (1) · Carcinoma, Squamous Cell (1) · Esophageal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Graft vs Host Disease (1) · Leukemia, Prolymphocytic, T-Cell (1) · Leukemia, T-Cell (1) · Lymphoma (1) · Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Cutaneous (1) · Lymphoma, T-Cell, Peripheral (1) · Neoplasms, Plasma Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
M.D. Anderson Cancer Center (1) · Mian XI (1) · Nanfang Hospital, Southern Medical University (1) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1) · Oslo University Hospital (1) · University of Sao Paulo (1) · Xuzhou Medical University (1)
United States (3) · China (2) · Brazil (1) · Denmark (1) · Norway (1) · Sweden (1)
Angelita Habr-Gama, MD, PhD (1) · Carlos A Buchpiguel, MD, PhD (1) · George L Chen, MD (1) · Jeremy L Davis, M.D. (1) · Joaquim J Gama-Rodrigues, MD, PhD (1) · Jonathan Brammer, MD (1) · Longzhen Zhang, MD (1) · Mian XI, MD (1) · Qifa Liu, MD (1) · Rodrigo O Perez, MD (1)
PMID 22086847, PMID 22580120, PMID 24509716, PMID 26911200, PMID 27152857, PMID 39638553